The first pan-European survey of depression in the community (DEPRES I) demonstrated that 17% of the general population suffer from depression (major depression, minor depression, or depressive symptoms).
This article describes findings from a second phase of DEPRES (DEPRES II), in which detailed interviews based on a semi-structured questionnaire (78 questions) were conducted with 1884 DEPRES I participants who had suffered from depression and who consulted a healthcare professional about their symptoms during the previous 6 months.
The mean time from onset of depression was 45 months, and the most commonly experienced symptoms during the latest period were low mood (76%), tiredness (73%) and sleep problems (63%). During the previous 6 months, respondents had been unable to undertake normal activities because of their depression for a mean of 30 days, and a mean of 20 days of work had been lost to depression by those in paid employment.
Approximately one-third of respondents (30%) had received an antidepressant during the latest period of depression.
Significantly more respondents given a selective serotonin reputake inhibitor found that their treatment made them feel more like their normal self than those given a tricyclic antidepressant, and fewer reported treatment-related concentration lapses, weight problems, and heavy-headedness (all P<0.05). (...)
Mots-clés Pascal : Antidépresseur, Psychotrope, Utilisation, Etat dépressif, Trouble humeur, Symptomatologie, Evolution, Homme, Epidémiologie, Europe, Chimiothérapie, Prescription médicale, Efficacité traitement
Mots-clés Pascal anglais : Antidepressant agent, Psychotropic, Use, Depression, Mood disorder, Symptomatology, Evolution, Human, Epidemiology, Europe, Chemotherapy, Medical prescription, Treatment efficiency
Notice produite par :
Inist-CNRS - Institut de l'Information Scientifique et Technique
Cote : 99-0296631
Code Inist : 002B18C07A. Création : 16/11/1999.